Power Law company profile

Cardior Pharmaceuticals

Biotech & Life Sciences · Hanover, Germany · Founded 2016 Unicorn

Non-coding RNA-based therapeutics in heart failure

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

<$1M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

13 investors on Cardior Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Bristol-Myers Squibb

HTGF

EQT Life Sciences

Series B+ 10 investors entered at this stage

Coparion

FundPlus

Inkef

Max Planck Society

BioMed Partners

Max Planck Innovation

Max Planck Institute for Gravitational Physics

Hadean Ventures

Sunstone Life Science Ventures

Medizinische Hochschule Hannover

Global footprint

Where Cardior Pharmaceuticals has talent and traffic

Workforce by country

1 countries with
team presence

🇩🇪 Germany100%

1 country shown

Web traffic by country

50 monthly visits
across markets

🇩🇪 Germany200%

Top 1 markets shown

Patent intelligence

$2M patent portfolio · 3 active families

Estimated portfolio value

$2M

0.21% of valuation · 2977.2× smaller than top peer Janssen Vaccines ($7.1B)

3 active patent families

Where Cardior Pharmaceuticals innovates microRNAOligonucleotideFibrosisRat heartNucleotide

Where Cardior Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Cardior Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Cardior Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Cardior Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cardior Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles